We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses (FXR#2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05219916
Recruitment Status : Terminated (It is unlikely that the scientific question will ever be answered. Thus, it would be considered unethical to continue the trial.)
First Posted : February 2, 2022
Last Update Posted : March 13, 2023
Information provided by (Responsible Party):
Hospices Civils de Lyon

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 22, 2022
Actual Study Completion Date : July 22, 2022